Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REZAFUNGIN vs RIFAMPICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REZAFUNGIN vs RIFAMPICIN: Safety Overview

Metric REZAFUNGIN RIFAMPICIN
Total FAERS Reports 108 179
Deaths Reported 12 34
Death Rate 11.1% 19.0%
Hospitalizations 20 79
Average Patient Age 53.8 yrs 46.8 yrs
% Female Patients 54.3% N/A
FDA Approval Date Mar 22, 2023 N/A
Manufacturer Melinta Therapeutics, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A